Target intelligence / Profile preview

SON DNA- and RNA-binding protein (SON)

Target
SON
Molecular classification
Transcription factor, Splicing factor, DNA-binding protein, RNA-binding protein, Other
01

Overview

SON is a large nuclear speckle-associated protein encoded by the SON gene, characterized by both DNA- and RNA-binding domains and multiple splicing-related motifs[1][2][3][4]. Functionally, it is an essential splicing co-factor that facilitates the efficient splicing and correct processing of weak splice sites, particularly in genes involved in the cell cycle, DNA repair, and genome maintenance[2][3][4]. SON is required for proper mitosis, chromosome alignment, genome stability, and centriole assembly, and its deficiency can cause severe developmental and cellular defects[1][2][3]. Mutations or aberrant isoform expression of SON are implicated in neurodevelopmental syndromes (such as ZTTK syndrome), glioblastoma, hematologic malignancies (like myelodysplastic syndromes and acute myeloid leukemia), and possibly other cancers, in part due to its role in regulating the splicing and expression of oncogenes and tumor suppressors[1][3][4][6]. SON is not classified as a classic therapeutic target (e.g., receptor, enzyme, transporter) but is a critical nuclear factor influencing RNA metabolism and genome stability.

Other names
BASS1Bax antagonist selected in saccharomyces 1NRE-binding proteinNegative regulatory element-binding proteinC21orf50DBP5KIAA1019NREBP
02

Biological functions

RNA splicingCell cycle regulationDNA repairGenome stabilityRegulation of gene expressionHematopoietic cell differentiationRegulation of apoptosis
03

Disease associations

CancerHematologic malignancy (e.g., myelodysplastic syndromes, acute myeloid leukemia)Developmental disorders (e.g., ZTTK syndrome)Neurodevelopmental disorderOther
04

Biomarkers

SON protein isoform expression (e.g., aberrant/truncated isoforms in myeloid neoplasms)

Beyond the preview

Go deeper on SON DNA- and RNA-binding protein (SON).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SON DNA- and RNA-binding protein (SON).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call